iBio, Inc. IBIO
NASDAQ IBIO
$0.85 +0.03 (+3.04%)
As of: Oct 21, 2026 · 2:17 PM EDT

iBio (IBIO) Work In Process (2016 - 2022)

Updated

iBio (IBIO) recorded Work In Process of $4,000 in fiscal Q4 2022 (quarter ended Jun 30, 2022), down 85.2% from $27,000 a year earlier.

Analysis

iBio (IBIO) Work In Process (2016 - 2022) Analysis & Trends

Starting with fiscal Q3 2016, iBio's Work In Process history includes 13 quarters.

  • Annual Work In Process has a five-year compound annual growth rate of -31.2% (FY2017 to FY2022).
  • Across earlier fiscal years, Work In Process came in at $27,000 in FY2021 (-96.6%) and $798,000 in FY2020.
  • The fiscal Q4 2022 figure is the lowest quarterly Work In Process in data going back to fiscal Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 iBio 88.20 Mn -177.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4,000.00
Dec 31, 2021 31,000.00
Sep 30, 2021 57,000.00
Jun 30, 2021 27,000.00
Mar 31, 2021 432,000.00
Dec 31, 2020 1.07 Mn
Sep 30, 2020 843,000.00
Jun 30, 2020 798,000.00
Jun 30, 2017 26,000.00
Mar 31, 2017 60,000.00
Dec 31, 2016 27,000.00
Jun 30, 2016 22,000.00
Mar 31, 2016 58,000.00
API Access

iBio Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=IBIO&period=max&api_key=YOUR_API_KEY